RPRX

Royalty Pharma plc NMS · RPRX

$57.69 +0.40 (+0.70%)

Neutral · +0.78σ

+ Compare Open in Sniper

Valuation

Market cap $33.2B

P/E (ttm) 30.4

Forward P/E 10.3

Beta (5y) 0.42

Shares out 443.3M

Div yield 1.64%

Profitability & returns

ROE 13.8%

Net margin 33.9%

FCF margin -40.2%

Debt / equity 0.90

Trading information

Last price $57.69

Day range $56.90 – $57.78

52-wk range $39.02 – $59.44

Avg volume 3.8M

RSI (2) 55.9

Trend zone Neutral

52-week range · today's price

$39.02$59.44

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-05

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has …